Evidence map›Paper›PMID 32488546›Full record

ArticleJournal of molecular medicine (Berlin, Germany)2020

Impact of β-glycerophosphate on the bioenergetic profile of vascular smooth muscle cells.

Ioana Alesutan, Franco Moritz, Tatjana Haider, Sun Shouxuan, Can Gollmann-Tepeköylü, Johannes Holfeld, Burkert Pieske, Florian Lang, Kai-Uwe Eckardt, Silke Sophie Heinzmann and 1 more

Open access · hybridAbstract read
In one paragraph

Article in Journal of molecular medicine (Berlin, Germany), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Insights Into the Role of Mitochondria in Vascular Calcification.Frontiers in cardiovascular medicine · 2022
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 2 countries.

Ioana AlesutanInstitute for Physiology and Pathophysiology, Johannes Kepler University, Altenberger Strasse 69, 4040, Linz, Austria. ioana.alesutan@jku.at.ORCID http://orcid.org/0000-0002-2145-3653
Franco MoritzAnalytical BioGeoChemistry, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany.
Tatjana HaiderInstitute for Physiology and Pathophysiology, Johannes Kepler University, Altenberger Strasse 69, 4040, Linz, Austria.
Sun ShouxuanInstitute for Physiology and Pathophysiology, Johannes Kepler University, Altenberger Strasse 69, 4040, Linz, Austria.
Can Gollmann-TepeköylüUniversity Clinic of Cardiac Surgery, Medical University of Innsbruck, Innsbruck, Austria.
Johannes HolfeldUniversity Clinic of Cardiac Surgery, Medical University of Innsbruck, Innsbruck, Austria.
Burkert PieskeDZHK (German Centre for Cardiovascular Research), partner site Berlin, Berlin, Germany.
Florian LangDepartment of Physiology I, Eberhard-Karls University, Tubingen, Germany.
Kai-Uwe EckardtDepartment of Nephrology and Medical Intensive Care, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Silke Sophie HeinzmannAnalytical BioGeoChemistry, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany.
Jakob VoelklInstitute for Physiology and Pathophysiology, Johannes Kepler University, Altenberger Strasse 69, 4040, Linz, Austria.
Johannes Kepler University of Linz · ATHelmholtz Zentrum München · DEInnsbruck Medical University · ATCharité - Universitätsmedizin Berlin · DEDeutsches Herzzentrum der Charité · DEUniversity of Tübingen · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In chronic kidney disease, hyperphosphatemia is a key pathological factor promoting medial vascular calcification, a common complication associated with cardiovascular events and mortality. This active pathophysiological process involves osteo-/chondrogenic transdifferentiation of vascular smooth muscle cells (VSMCs) via complex intracellular mechanisms that are still incompletely understood. Little is known about the effects of phosphate on the bioenergetic profile of VSMCs during the onset of this process. Therefore, the present study explored the effects of the phosphate donor β-glycerophosphate on cellular bioenergetics of VSMCs. Mitochondrial and glycolytic functions were determined utilizing extracellular flux analysis in primary human aortic VSMCs following exposure to β-glycerophosphate. In VSMCs, β-glycerophosphate increased basal respiration, mitochondrial ATP production as well as proton leak and decreased spare respiratory capacity and coupling efficiency, but did not modify non-mitochondrial or maximal respiration. β-Glycerophosphate-treated VSMCs had higher ability to increase mitochondrial glutamine and long-chain fatty acid usage as oxidation substrates to meet their energy demand. β-Glycerophosphate did not modify glycolytic function or basal and glycolytic proton efflux rate. In contrast, β-glycerophosphate increased non-glycolytic acidification. β-Glycerophosphate-treated VSMCs had a more oxidative and less glycolytic phenotype, but a reduced ability to respond to stressed conditions via mitochondrial respiration. Moreover, compounds targeting components of mitochondrial respiration modulated β-glycerophosphate-induced oxidative stress, osteo-/chondrogenic signalling and mineralization of VSMCs. In conclusion, β-glycerophosphate modifies key parameters of mitochondrial function and cellular bioenergetics in VSMCs that may contribute to the onset of phenotypical transdifferentiation and calcification. These observations advance the understanding of the role of energy metabolism in VSMC physiology and pathophysiology of vascular calcification during hyperphosphatemia. KEY MESSAGES: β-Glycerophosphate modifies key parameters of mitochondrial respiration in VSMCs. β-Glycerophosphate induces changes in mitochondrial fuel choice in VSMCs. β-Glycerophosphate promotes a more oxidative and less glycolytic phenotype of VSMCs. β-Glycerophosphate triggers mitochondrial-dependent oxidative stress in VSMCs. Bioenergetics impact β-glycerophosphate-induced VSMC calcification.

Indexed as

AortaCells, CulturedCell TransdifferentiationChondrogenesisEnergy MetabolismGlycerophosphatesHumansHyperphosphatemiaMuscle, Smooth, VascularMyocytes, Smooth MuscleOsteogenesisPhosphatesRenal Insufficiency, ChronicSignal TransductionVascular Calcificationbeta-glycerophosphoric acidGlycerophosphatesPhosphatesBioenergeticsGlycolysisMitochondrial respirationVascular calcificationVascular smooth muscle cellsβ-Glycerophosphate

Identifiers

PMID32488546
PMCPMC7343738
OpenAlexW3032587261

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.